share_log

The Analyst Verdict: Clene In The Eyes Of 5 Experts

The Analyst Verdict: Clene In The Eyes Of 5 Experts

分析師的判決:5位專家眼中的克倫
Benzinga ·  04/17 16:02
Ratings for Clene (NASDAQ:CLNN) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中,有5位分析師提供了Clene(納斯達克股票代碼:CLNN)的評級,顯示了看漲和看跌的混合前景。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級,簡要介紹了過去30天中不斷變化的情緒,並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $6.6, along with a high estimate of $7.00 and a low estimate of $5.00. Observing a downward trend, the current average is 5.71% lower than the prior average price target of $7.00.
分析師提供了更深入的見解,確定了12個月的目標股價,平均目標價爲6.6美元,最高估計爲7.00美元,低估值爲5.00美元。觀察下降趨勢,當前的平均價格比之前的平均目標價7.00美元低5.71%。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級:詳細審查
A comprehensive examination of how...
對金融專家...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論